

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.30995051 |
| 2 | negative regulation of interleukin-12 production (GO:0032695) | 5.25521779 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 5.18411942 |
| 4 | NADH metabolic process (GO:0006734) | 4.20703438 |
| 5 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.17931662 |
| 6 | regulation of vitamin metabolic process (GO:0030656) | 4.16238912 |
| 7 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.10196379 |
| 8 | regulation of chronic inflammatory response (GO:0002676) | 4.09795264 |
| 9 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.08305297 |
| 10 | regulation of sequestering of triglyceride (GO:0010889) | 4.04181291 |
| 11 | positive regulation of heat generation (GO:0031652) | 4.02653394 |
| 12 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.01251460 |
| 13 | type I interferon signaling pathway (GO:0060337) | 3.97562788 |
| 14 | cellular response to type I interferon (GO:0071357) | 3.97562788 |
| 15 | response to type I interferon (GO:0034340) | 3.97413133 |
| 16 | response to peptidoglycan (GO:0032494) | 3.95521314 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.91824318 |
| 18 | germinal center formation (GO:0002467) | 3.89939833 |
| 19 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.89173933 |
| 20 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.83472623 |
| 21 | positive regulation of lipid storage (GO:0010884) | 3.79371304 |
| 22 | T-helper 1 type immune response (GO:0042088) | 3.78963617 |
| 23 | * respiratory electron transport chain (GO:0022904) | 3.77360586 |
| 24 | lysine metabolic process (GO:0006553) | 3.73304392 |
| 25 | lysine catabolic process (GO:0006554) | 3.73304392 |
| 26 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.72254007 |
| 27 | regulation of fever generation (GO:0031620) | 3.67830873 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.65436748 |
| 29 | * electron transport chain (GO:0022900) | 3.64445285 |
| 30 | oxidative phosphorylation (GO:0006119) | 3.63351523 |
| 31 | succinate metabolic process (GO:0006105) | 3.60775980 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.59280967 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.59280967 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.59280967 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.59280967 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.59280967 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 3.59280967 |
| 38 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.57409374 |
| 39 | * hydrogen peroxide biosynthetic process (GO:0050665) | 3.55563096 |
| 40 | positive regulation of type 2 immune response (GO:0002830) | 3.55147309 |
| 41 | regulation of cofactor metabolic process (GO:0051193) | 3.51263107 |
| 42 | regulation of coenzyme metabolic process (GO:0051196) | 3.51263107 |
| 43 | oxaloacetate metabolic process (GO:0006107) | 3.50292321 |
| 44 | regulation of chemokine biosynthetic process (GO:0045073) | 3.48487466 |
| 45 | regulation of podosome assembly (GO:0071801) | 3.48112934 |
| 46 | defense response to protozoan (GO:0042832) | 3.43178014 |
| 47 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.42789266 |
| 48 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.42640277 |
| 49 | 2-oxoglutarate metabolic process (GO:0006103) | 3.42570536 |
| 50 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.42116161 |
| 51 | response to protozoan (GO:0001562) | 3.40554490 |
| 52 | low-density lipoprotein particle clearance (GO:0034383) | 3.40337870 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.39447376 |
| 54 | aldehyde catabolic process (GO:0046185) | 3.38417138 |
| 55 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.36188404 |
| 56 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.33071930 |
| 57 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.30055963 |
| 58 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.28149480 |
| 59 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.27805093 |
| 60 | ATP synthesis coupled proton transport (GO:0015986) | 3.27805093 |
| 61 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.22736937 |
| 62 | regulation of interleukin-12 production (GO:0032655) | 3.21962704 |
| 63 | fatty acid beta-oxidation (GO:0006635) | 3.21167582 |
| 64 | respiratory burst (GO:0045730) | 3.20381032 |
| 65 | macrophage activation (GO:0042116) | 3.18529419 |
| 66 | regulation of cholesterol storage (GO:0010885) | 3.17991737 |
| 67 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.16463979 |
| 68 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.16417189 |
| 69 | negative regulation of cell killing (GO:0031342) | 3.16417189 |
| 70 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.16348973 |
| 71 | positive regulation of interferon-beta production (GO:0032728) | 3.16121981 |
| 72 | NIK/NF-kappaB signaling (GO:0038061) | 3.14909588 |
| 73 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.14854580 |
| 74 | response to muramyl dipeptide (GO:0032495) | 3.12780137 |
| 75 | fatty acid transmembrane transport (GO:1902001) | 3.10250554 |
| 76 | positive regulation of acute inflammatory response (GO:0002675) | 3.08084403 |
| 77 | neutrophil activation involved in immune response (GO:0002283) | 3.07476564 |
| 78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06580936 |
| 79 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.06285470 |
| 80 | * reactive oxygen species biosynthetic process (GO:1903409) | 3.04550922 |
| 81 | immunoglobulin mediated immune response (GO:0016064) | 3.03497398 |
| 82 | tryptophan catabolic process (GO:0006569) | 3.03235243 |
| 83 | indole-containing compound catabolic process (GO:0042436) | 3.03235243 |
| 84 | indolalkylamine catabolic process (GO:0046218) | 3.03235243 |
| 85 | granulocyte activation (GO:0036230) | 3.02798065 |
| 86 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.01587367 |
| 87 | aspartate family amino acid catabolic process (GO:0009068) | 2.99539468 |
| 88 | cellular response to lipopolysaccharide (GO:0071222) | 2.99091638 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.98850623 |
| 90 | cellular response to molecule of bacterial origin (GO:0071219) | 2.98683384 |
| 91 | phagosome maturation (GO:0090382) | 2.98430929 |
| 92 | microglial cell activation (GO:0001774) | 2.97595380 |
| 93 | NAD metabolic process (GO:0019674) | 2.97382029 |
| 94 | regulation of lipid storage (GO:0010883) | 2.96423308 |
| 95 | branched-chain amino acid catabolic process (GO:0009083) | 2.95930914 |
| 96 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.94626263 |
| 97 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.92493983 |
| 98 | regulation of gamma-delta T cell activation (GO:0046643) | 2.92260787 |
| 99 | kynurenine metabolic process (GO:0070189) | 2.92031535 |
| 100 | carnitine shuttle (GO:0006853) | 2.91780655 |
| 101 | myeloid dendritic cell differentiation (GO:0043011) | 2.91454931 |
| 102 | * positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.88434747 |
| 103 | regulation of type 2 immune response (GO:0002828) | 2.85567175 |
| 104 | positive regulation of interleukin-6 production (GO:0032755) | 2.85108331 |
| 105 | regulation of heat generation (GO:0031650) | 2.83849336 |
| 106 | plasma lipoprotein particle clearance (GO:0034381) | 2.82568300 |
| 107 | detection of external biotic stimulus (GO:0098581) | 2.82213531 |
| 108 | regulation of T-helper cell differentiation (GO:0045622) | 2.82021358 |
| 109 | * regulation of nitric oxide biosynthetic process (GO:0045428) | 2.81943876 |
| 110 | interferon-gamma secretion (GO:0072643) | 2.81504112 |
| 111 | detection of other organism (GO:0098543) | 2.79925524 |
| 112 | lipid oxidation (GO:0034440) | 2.79868039 |
| 113 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.79073098 |
| 114 | positive regulation of interferon-alpha production (GO:0032727) | 2.78982136 |
| 115 | fatty acid oxidation (GO:0019395) | 2.78949838 |
| 116 | negative regulation of lipid storage (GO:0010888) | 2.78674705 |
| 117 | acetyl-CoA metabolic process (GO:0006084) | 2.78624962 |
| 118 | negative regulation of growth of symbiont in host (GO:0044130) | 2.78318682 |
| 119 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.78318682 |
| 120 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.78318682 |
| 121 | regulation of growth of symbiont in host (GO:0044126) | 2.78318682 |
| 122 | positive regulation of interleukin-12 production (GO:0032735) | 2.77611229 |
| 123 | fatty acid catabolic process (GO:0009062) | 2.77610801 |
| 124 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.77489006 |
| 125 | cellular ketone body metabolic process (GO:0046950) | 2.75846275 |
| 126 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.75553047 |
| 127 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.74743720 |
| 128 | branched-chain amino acid metabolic process (GO:0009081) | 2.74013379 |
| 129 | tricarboxylic acid metabolic process (GO:0072350) | 2.73613368 |
| 130 | cofactor catabolic process (GO:0051187) | 2.73520870 |
| 131 | lymphocyte chemotaxis (GO:0048247) | 2.73107569 |
| 132 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.72873708 |
| 133 | negative regulation of viral genome replication (GO:0045071) | 2.72617675 |
| 134 | monocyte chemotaxis (GO:0002548) | 2.70474279 |
| 135 | sarcomere organization (GO:0045214) | 2.70381759 |
| 136 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.70066625 |
| 137 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.69777458 |
| 138 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.68857544 |
| 139 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.68814557 |
| 140 | myeloid cell activation involved in immune response (GO:0002275) | 2.68638879 |
| 141 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.68610241 |
| 142 | neutrophil activation (GO:0042119) | 2.68466328 |
| 143 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.68444687 |
| 144 | glyoxylate metabolic process (GO:0046487) | 2.68365829 |
| 145 | heart process (GO:0003015) | 2.68348208 |
| 146 | heart contraction (GO:0060047) | 2.68348208 |
| 147 | valine metabolic process (GO:0006573) | 2.67969993 |
| 148 | negative regulation of T cell mediated immunity (GO:0002710) | 2.67810612 |
| 149 | cellular response to interferon-gamma (GO:0071346) | 2.67457727 |
| 150 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.67350139 |
| 151 | regulation of sulfur metabolic process (GO:0042762) | 2.67263746 |
| 152 | macrophage activation involved in immune response (GO:0002281) | 2.65795213 |
| 153 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.65016338 |
| 154 | regulation of interferon-alpha production (GO:0032647) | 2.63268724 |
| 155 | positive regulation of lipid catabolic process (GO:0050996) | 2.62503350 |
| 156 | regulation of relaxation of muscle (GO:1901077) | 2.62065657 |
| 157 | cellular response to zinc ion (GO:0071294) | 2.61287884 |
| 158 | myofibril assembly (GO:0030239) | 2.56974769 |
| 159 | carnitine metabolic process (GO:0009437) | 2.56819324 |
| 160 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.55203256 |
| 161 | response to host immune response (GO:0052572) | 2.50987202 |
| 162 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.50987202 |
| 163 | lipid storage (GO:0019915) | 2.50840253 |
| 164 | monocarboxylic acid catabolic process (GO:0072329) | 2.50117736 |
| 165 | regulation of mononuclear cell migration (GO:0071675) | 2.49767419 |
| 166 | negative regulation of lipid catabolic process (GO:0050995) | 2.49417772 |
| 167 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.49295771 |
| 168 | short-chain fatty acid metabolic process (GO:0046459) | 2.49183607 |
| 169 | amino-acid betaine metabolic process (GO:0006577) | 2.48435902 |
| 170 | detection of molecule of bacterial origin (GO:0032490) | 2.47105168 |
| 171 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.45831685 |
| 172 | cysteine metabolic process (GO:0006534) | 2.41765720 |
| 173 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.41452286 |
| 174 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.41452286 |
| 175 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.41350567 |
| 176 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40489569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.91042028 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.70829939 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.60131716 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.67272022 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.60901397 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.91905504 |
| 7 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.47794675 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.46265942 |
| 9 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.45756520 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.44434804 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.34599008 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.31526602 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.19983538 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.16212261 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.04404268 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.01732109 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.96277603 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.73114356 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.68546335 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.42115610 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.30579696 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28827452 |
| 23 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19490971 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17251553 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.15851475 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.13429592 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02945062 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.88440958 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.86166457 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79943592 |
| 31 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71906736 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70295165 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68052135 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65388654 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58488054 |
| 36 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58283535 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57402657 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.56791415 |
| 39 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.56777602 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54547088 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50340686 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49573327 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46914931 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46425463 |
| 45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45205823 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37253205 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37253205 |
| 48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.36981828 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36002865 |
| 50 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.35968831 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35351500 |
| 52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34967778 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31848049 |
| 54 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25310775 |
| 55 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25006315 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22937995 |
| 57 | MYB_26560356_Chip-Seq_TH2_Human | 1.20564458 |
| 58 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.19824710 |
| 59 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18489062 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.18289138 |
| 61 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16402393 |
| 62 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15604667 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15025372 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12301426 |
| 65 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.11129295 |
| 66 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09027811 |
| 67 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.09009899 |
| 68 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08518638 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08507579 |
| 70 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.06675380 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06043230 |
| 72 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04805262 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04625925 |
| 74 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.04157322 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04156251 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01532064 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00242543 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99616863 |
| 79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98044584 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96448340 |
| 81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96019668 |
| 82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95956835 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95107686 |
| 84 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94899991 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94400468 |
| 86 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93986192 |
| 87 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.93843090 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93621251 |
| 89 | MAF_26560356_Chip-Seq_TH1_Human | 0.92940746 |
| 90 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91041661 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 0.89487197 |
| 92 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88188066 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88117924 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87328123 |
| 95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87310539 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86513495 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.86308781 |
| 98 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.84680046 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84633228 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84311392 |
| 101 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83858315 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83495701 |
| 103 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82704576 |
| 104 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.81990215 |
| 105 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.81481273 |
| 106 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.81458278 |
| 107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.81148833 |
| 108 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.80561530 |
| 109 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.80230234 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80139887 |
| 111 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.80038770 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79851615 |
| 113 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78956228 |
| 114 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.78630869 |
| 115 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78451988 |
| 116 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.77552162 |
| 117 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77152976 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77142615 |
| 119 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.75717119 |
| 120 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75717119 |
| 121 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.74950551 |
| 122 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.74455214 |
| 123 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.74444798 |
| 124 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.73456206 |
| 125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72482971 |
| 126 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72419246 |
| 127 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.72322892 |
| 128 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72292704 |
| 129 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.71913216 |
| 130 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71653325 |
| 131 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.70673806 |
| 132 | GATA3_26560356_Chip-Seq_TH2_Human | 0.70284916 |
| 133 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.69824688 |
| 134 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.69822199 |
| 135 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.69625969 |
| 136 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.69420417 |
| 137 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.69186078 |
| 138 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.68892392 |
| 139 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.68813618 |
| 140 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.68478893 |
| 141 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.66926407 |
| 142 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.66784509 |
| 143 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.66680874 |
| 144 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66303163 |
| 145 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.66210660 |
| 146 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.65957886 |
| 147 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65756532 |
| 148 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.65657451 |
| 149 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.65239540 |
| 150 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65009994 |
| 151 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.64944880 |
| 152 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.63608236 |
| 153 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.63564994 |
| 154 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.63472063 |
| 155 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62075401 |
| 156 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.62011726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.76568197 |
| 2 | * MP0003646_muscle_fatigue | 3.67352722 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 2.94699742 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.79536556 |
| 5 | MP0004084_abnormal_cardiac_muscle | 2.76414378 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.73575470 |
| 7 | MP0009785_altered_susceptibility_to | 2.69959641 |
| 8 | MP0003724_increased_susceptibility_to | 2.63361719 |
| 9 | MP0005360_urolithiasis | 2.61796845 |
| 10 | MP0004215_abnormal_myocardial_fiber | 2.49248449 |
| 11 | MP0004510_myositis | 2.42330650 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.35204442 |
| 13 | MP0005671_abnormal_response_to | 2.34756364 |
| 14 | MP0009840_abnormal_foam_cell | 2.31216448 |
| 15 | MP0001800_abnormal_humoral_immune | 2.25420713 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.25034088 |
| 17 | * MP0006036_abnormal_mitochondrial_physio | 2.24285062 |
| 18 | * MP0004130_abnormal_muscle_cell | 2.23800942 |
| 19 | MP0004036_abnormal_muscle_relaxation | 2.23533671 |
| 20 | MP0003436_decreased_susceptibility_to | 2.14785886 |
| 21 | MP0000751_myopathy | 2.11429651 |
| 22 | * MP0003186_abnormal_redox_activity | 2.08562718 |
| 23 | MP0008004_abnormal_stomach_pH | 2.05411222 |
| 24 | MP0009764_decreased_sensitivity_to | 2.00521808 |
| 25 | MP0005332_abnormal_amino_acid | 1.98767862 |
| 26 | MP0000343_altered_response_to | 1.98367179 |
| 27 | MP0000749_muscle_degeneration | 1.97356929 |
| 28 | MP0006054_spinal_hemorrhage | 1.96711153 |
| 29 | * MP0005330_cardiomyopathy | 1.95552984 |
| 30 | MP0006082_CNS_inflammation | 1.88679307 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.87790877 |
| 32 | MP0005365_abnormal_bile_salt | 1.87320835 |
| 33 | MP0009278_abnormal_bone_marrow | 1.83573750 |
| 34 | MP0005083_abnormal_biliary_tract | 1.83477964 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.82330207 |
| 36 | * MP0002332_abnormal_exercise_endurance | 1.82166280 |
| 37 | MP0000685_abnormal_immune_system | 1.81380771 |
| 38 | MP0002254_reproductive_system_inflammat | 1.78650823 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.77360874 |
| 40 | * MP0002972_abnormal_cardiac_muscle | 1.75852992 |
| 41 | MP0002419_abnormal_innate_immunity | 1.75413993 |
| 42 | MP0003303_peritoneal_inflammation | 1.73810170 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.73618996 |
| 44 | MP0001819_abnormal_immune_cell | 1.73446881 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.72702990 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.70871790 |
| 47 | MP0001544_abnormal_cardiovascular_syste | 1.68921561 |
| 48 | MP0005385_cardiovascular_system_phenoty | 1.68921561 |
| 49 | * MP0005535_abnormal_body_temperature | 1.68910008 |
| 50 | * MP0005319_abnormal_enzyme/_coenzyme | 1.65517645 |
| 51 | MP0003828_pulmonary_edema | 1.65345346 |
| 52 | MP0002405_respiratory_system_inflammati | 1.64689414 |
| 53 | MP0008875_abnormal_xenobiotic_pharmacok | 1.63488541 |
| 54 | MP0005310_abnormal_salivary_gland | 1.59949228 |
| 55 | MP0005025_abnormal_response_to | 1.59261493 |
| 56 | MP0000750_abnormal_muscle_regeneration | 1.54733987 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.53759561 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.52676196 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.52676196 |
| 60 | * MP0008469_abnormal_protein_level | 1.49197699 |
| 61 | MP0004484_altered_response_of | 1.46365394 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.46244133 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.44260028 |
| 64 | MP0003448_altered_tumor_morphology | 1.43731456 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.42739340 |
| 66 | MP0003075_altered_response_to | 1.42257894 |
| 67 | * MP0004087_abnormal_muscle_fiber | 1.41098521 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.39399172 |
| 69 | MP0010329_abnormal_lipoprotein_level | 1.38228165 |
| 70 | MP0005000_abnormal_immune_tolerance | 1.37450766 |
| 71 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.34509113 |
| 72 | * MP0005620_abnormal_muscle_contractility | 1.34083762 |
| 73 | MP0001764_abnormal_homeostasis | 1.33178827 |
| 74 | MP0001853_heart_inflammation | 1.32825913 |
| 75 | MP0005451_abnormal_body_composition | 1.31660706 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.28166931 |
| 77 | * MP0006035_abnormal_mitochondrial_morpho | 1.28110510 |
| 78 | MP0000604_amyloidosis | 1.27405823 |
| 79 | MP0005670_abnormal_white_adipose | 1.24697363 |
| 80 | * MP0002118_abnormal_lipid_homeostasis | 1.24238155 |
| 81 | MP0005666_abnormal_adipose_tissue | 1.22729548 |
| 82 | MP0001501_abnormal_sleep_pattern | 1.22580294 |
| 83 | * MP0000716_abnormal_immune_system | 1.21626292 |
| 84 | * MP0002106_abnormal_muscle_physiology | 1.20162396 |
| 85 | MP0002971_abnormal_brown_adipose | 1.18107359 |
| 86 | MP0001533_abnormal_skeleton_physiology | 1.15971972 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 1.15927275 |
| 88 | * MP0003221_abnormal_cardiomyocyte_apopto | 1.15155143 |
| 89 | MP0003045_fibrosis | 1.10336130 |
| 90 | * MP0000609_abnormal_liver_physiology | 1.10135839 |
| 91 | MP0008260_abnormal_autophagy | 1.09813671 |
| 92 | MP0005166_decreased_susceptibility_to | 1.09081839 |
| 93 | MP0003091_abnormal_cell_migration | 1.08819932 |
| 94 | MP0003137_abnormal_impulse_conducting | 1.08742187 |
| 95 | MP0005165_increased_susceptibility_to | 1.08218618 |
| 96 | MP0000858_altered_metastatic_potential | 1.07221884 |
| 97 | MP0001845_abnormal_inflammatory_respons | 1.06137696 |
| 98 | MP0009763_increased_sensitivity_to | 1.05929653 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 1.05767030 |
| 100 | MP0009333_abnormal_splenocyte_physiolog | 1.03064937 |
| 101 | MP0004883_abnormal_blood_vessel | 1.01433642 |
| 102 | * MP0005266_abnormal_metabolism | 1.01027561 |
| 103 | MP0004858_abnormal_nervous_system | 1.00392221 |
| 104 | MP0010352_gastrointestinal_tract_polyps | 0.99901762 |
| 105 | MP0006138_congestive_heart_failure | 0.99120220 |
| 106 | * MP0010630_abnormal_cardiac_muscle | 0.98256390 |
| 107 | * MP0002398_abnormal_bone_marrow | 0.97394109 |
| 108 | MP0002269_muscular_atrophy | 0.97043022 |
| 109 | MP0009697_abnormal_copulation | 0.97014787 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.96472504 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.94149199 |
| 112 | * MP0002078_abnormal_glucose_homeostasis | 0.93340262 |
| 113 | * MP0009643_abnormal_urine_homeostasis | 0.93046974 |
| 114 | MP0003252_abnormal_bile_duct | 0.92442728 |
| 115 | MP0004019_abnormal_vitamin_homeostasis | 0.92437225 |
| 116 | * MP0005376_homeostasis/metabolism_phenot | 0.90489065 |
| 117 | MP0009046_muscle_twitch | 0.89082955 |
| 118 | MP0003763_abnormal_thymus_physiology | 0.87335060 |
| 119 | MP0005387_immune_system_phenotype | 0.87262341 |
| 120 | MP0001790_abnormal_immune_system | 0.87262341 |
| 121 | MP0005164_abnormal_response_to | 0.86207756 |
| 122 | MP0001663_abnormal_digestive_system | 0.85784964 |
| 123 | MP0002723_abnormal_immune_serum | 0.84746860 |
| 124 | * MP0002429_abnormal_blood_cell | 0.84729569 |
| 125 | MP0005390_skeleton_phenotype | 0.84720110 |
| 126 | MP0000689_abnormal_spleen_morphology | 0.84131457 |
| 127 | * MP0005369_muscle_phenotype | 0.83064517 |
| 128 | MP0002452_abnormal_antigen_presenting | 0.82309458 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.81752229 |
| 130 | MP0005076_abnormal_cell_differentiation | 0.81274936 |
| 131 | MP0002722_abnormal_immune_system | 0.80271845 |
| 132 | MP0004947_skin_inflammation | 0.79693561 |
| 133 | MP0003690_abnormal_glial_cell | 0.79310056 |
| 134 | MP0005464_abnormal_platelet_physiology | 0.78746247 |
| 135 | MP0001756_abnormal_urination | 0.78119970 |
| 136 | MP0005334_abnormal_fat_pad | 0.78079566 |
| 137 | MP0000249_abnormal_blood_vessel | 0.77728444 |
| 138 | MP0008874_decreased_physiological_sensi | 0.77540796 |
| 139 | * MP0003195_calcinosis | 0.77344435 |
| 140 | MP0000920_abnormal_myelination | 0.77019480 |
| 141 | MP0005647_abnormal_sex_gland | 0.72257322 |
| 142 | MP0001851_eye_inflammation | 0.72053042 |
| 143 | MP0002933_joint_inflammation | 0.71974269 |
| 144 | MP0004808_abnormal_hematopoietic_stem | 0.70910264 |
| 145 | MP0002277_abnormal_respiratory_mucosa | 0.69379005 |
| 146 | MP0005023_abnormal_wound_healing | 0.67650044 |
| 147 | MP0000371_diluted_coat_color | 0.66477156 |
| 148 | MP0003183_abnormal_peptide_metabolism | 0.65737938 |
| 149 | MP0003329_amyloid_beta_deposits | 0.58763067 |
| 150 | MP0003633_abnormal_nervous_system | 0.58633060 |
| 151 | MP0003950_abnormal_plasma_membrane | 0.57922398 |
| 152 | MP0005595_abnormal_vascular_smooth | 0.57352750 |
| 153 | MP0000465_gastrointestinal_hemorrhage | 0.56865593 |
| 154 | MP0009115_abnormal_fat_cell | 0.54400547 |
| 155 | MP0001542_abnormal_bone_strength | 0.53890419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retrobulbar optic neuritis (HP:0100654) | 6.44802890 |
| 2 | Optic neuritis (HP:0100653) | 6.44802890 |
| 3 | Orchitis (HP:0100796) | 6.23846531 |
| 4 | Myositis (HP:0100614) | 5.37861729 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.10618185 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.10618185 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 5.10618185 |
| 8 | Keratoconjunctivitis sicca (HP:0001097) | 4.50930670 |
| 9 | Keratoconjunctivitis (HP:0001096) | 4.18155432 |
| 10 | Nausea (HP:0002018) | 4.13398241 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 4.12002094 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.99181602 |
| 13 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.84593447 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.82603603 |
| 15 | Hepatic necrosis (HP:0002605) | 3.79330908 |
| 16 | Disinhibition (HP:0000734) | 3.74422144 |
| 17 | Sudden death (HP:0001699) | 3.63292220 |
| 18 | Acute encephalopathy (HP:0006846) | 3.63111570 |
| 19 | Cerebral edema (HP:0002181) | 3.59115178 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.51698745 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.50659610 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.50435557 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.48407205 |
| 24 | Neoplasm of head and neck (HP:0012288) | 3.45907486 |
| 25 | Esophageal neoplasm (HP:0100751) | 3.45907486 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.44601604 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.42774845 |
| 28 | Loss of speech (HP:0002371) | 3.39197412 |
| 29 | Gangrene (HP:0100758) | 3.32660980 |
| 30 | Myoglobinuria (HP:0002913) | 3.27888612 |
| 31 | Dysostosis multiplex (HP:0000943) | 3.22997386 |
| 32 | Vasculitis (HP:0002633) | 3.21830036 |
| 33 | Exercise-induced muscle cramps (HP:0003710) | 3.20703651 |
| 34 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.20383631 |
| 35 | Dicarboxylic aciduria (HP:0003215) | 3.20383631 |
| 36 | Generalized aminoaciduria (HP:0002909) | 3.18877872 |
| 37 | Hematochezia (HP:0002573) | 3.18436790 |
| 38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.18024648 |
| 39 | Recurrent bacterial skin infections (HP:0005406) | 3.17868132 |
| 40 | Mitochondrial inheritance (HP:0001427) | 3.17125815 |
| 41 | Progressive macrocephaly (HP:0004481) | 3.16813120 |
| 42 | Hepatocellular necrosis (HP:0001404) | 3.14398423 |
| 43 | Pulmonary infiltrates (HP:0002113) | 3.13894627 |
| 44 | Hyperglycinuria (HP:0003108) | 3.11513978 |
| 45 | Increased CSF lactate (HP:0002490) | 3.10242906 |
| 46 | Ketoacidosis (HP:0001993) | 3.09879180 |
| 47 | Hemoptysis (HP:0002105) | 3.08296938 |
| 48 | T lymphocytopenia (HP:0005403) | 2.98098847 |
| 49 | Arterial thrombosis (HP:0004420) | 2.97103389 |
| 50 | Gastrointestinal infarctions (HP:0005244) | 2.94968530 |
| 51 | Axonal loss (HP:0003447) | 2.92589215 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.89644947 |
| 53 | Rhabdomyolysis (HP:0003201) | 2.89526558 |
| 54 | Lactic acidosis (HP:0003128) | 2.89317927 |
| 55 | Palpitations (HP:0001962) | 2.88142117 |
| 56 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.87004349 |
| 57 | Hyperammonemia (HP:0001987) | 2.86827851 |
| 58 | Calf muscle hypertrophy (HP:0008981) | 2.84824596 |
| 59 | Exercise-induced myalgia (HP:0003738) | 2.84363655 |
| 60 | Ventricular tachycardia (HP:0004756) | 2.84071846 |
| 61 | Ketosis (HP:0001946) | 2.81871142 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.79651928 |
| 63 | Abnormality of glycolysis (HP:0004366) | 2.79120962 |
| 64 | Increased serum pyruvate (HP:0003542) | 2.79120962 |
| 65 | Lethargy (HP:0001254) | 2.77826637 |
| 66 | Amyloidosis (HP:0011034) | 2.76925488 |
| 67 | Proximal tubulopathy (HP:0000114) | 2.72487266 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.71154422 |
| 69 | Recurrent fungal infections (HP:0002841) | 2.69859053 |
| 70 | Encephalitis (HP:0002383) | 2.69300973 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.66060961 |
| 72 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.65743868 |
| 73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.65743868 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.65743868 |
| 75 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.65344757 |
| 76 | Abnormality of alanine metabolism (HP:0010916) | 2.65344757 |
| 77 | Hyperalaninemia (HP:0003348) | 2.65344757 |
| 78 | Recurrent skin infections (HP:0001581) | 2.63182860 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 2.62022695 |
| 80 | Inappropriate behavior (HP:0000719) | 2.60758446 |
| 81 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.59520697 |
| 82 | Mutism (HP:0002300) | 2.58924167 |
| 83 | Glomerulonephritis (HP:0000099) | 2.58441923 |
| 84 | Abnormality of glycine metabolism (HP:0010895) | 2.56541266 |
| 85 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.56541266 |
| 86 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.54775286 |
| 87 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.54735450 |
| 88 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.54735450 |
| 89 | Autoimmune thrombocytopenia (HP:0001973) | 2.53802207 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 2.52411033 |
| 91 | Respiratory failure (HP:0002878) | 2.52158457 |
| 92 | Lipoatrophy (HP:0100578) | 2.51988587 |
| 93 | Xanthomatosis (HP:0000991) | 2.51618619 |
| 94 | Interstitial pulmonary disease (HP:0006530) | 2.51089564 |
| 95 | Pheochromocytoma (HP:0002666) | 2.50862894 |
| 96 | Tetraparesis (HP:0002273) | 2.50611261 |
| 97 | Anorexia (HP:0002039) | 2.47528652 |
| 98 | Atrial fibrillation (HP:0005110) | 2.46952337 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.45628731 |
| 100 | Mucopolysacchariduria (HP:0008155) | 2.45628731 |
| 101 | Parakeratosis (HP:0001036) | 2.45468192 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 2.45000865 |
| 103 | Stomatitis (HP:0010280) | 2.41747264 |
| 104 | Vomiting (HP:0002013) | 2.41225064 |
| 105 | Increased intramyocellular lipid droplets (HP:0012240) | 2.40794010 |
| 106 | Abnormality of the pleura (HP:0002103) | 2.40696193 |
| 107 | Vertigo (HP:0002321) | 2.40667604 |
| 108 | Pulmonary embolism (HP:0002204) | 2.40586945 |
| 109 | Neuroendocrine neoplasm (HP:0100634) | 2.39383540 |
| 110 | Increased serum ferritin (HP:0003281) | 2.38072340 |
| 111 | Myocardial infarction (HP:0001658) | 2.37890525 |
| 112 | Muscle fiber splitting (HP:0003555) | 2.37884440 |
| 113 | Episodic fever (HP:0001954) | 2.37433294 |
| 114 | Hyperglycinemia (HP:0002154) | 2.37231136 |
| 115 | Polyneuropathy (HP:0001271) | 2.37176919 |
| 116 | Metabolic acidosis (HP:0001942) | 2.36193699 |
| 117 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.35690115 |
| 118 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.35642692 |
| 119 | Syncope (HP:0001279) | 2.34291633 |
| 120 | Leukocytosis (HP:0001974) | 2.33655919 |
| 121 | Exercise intolerance (HP:0003546) | 2.33049955 |
| 122 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.32082313 |
| 123 | Abnormality of the pericardium (HP:0001697) | 2.30505073 |
| 124 | Recurrent viral infections (HP:0004429) | 2.29948626 |
| 125 | Primary atrial arrhythmia (HP:0001692) | 2.26981908 |
| 126 | Multiple enchondromatosis (HP:0005701) | 2.25477406 |
| 127 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.24258444 |
| 128 | Subaortic stenosis (HP:0001682) | 2.24258444 |
| 129 | Abnormality of the endocardium (HP:0004306) | 2.24181913 |
| 130 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.23894322 |
| 131 | Asymmetric septal hypertrophy (HP:0001670) | 2.22832114 |
| 132 | Peritonitis (HP:0002586) | 2.22348017 |
| 133 | Abnormality of serum amino acid levels (HP:0003112) | 2.20980745 |
| 134 | Nuclear cataract (HP:0100018) | 2.20297406 |
| 135 | Increased serum lactate (HP:0002151) | 2.19660349 |
| 136 | Spontaneous hematomas (HP:0007420) | 2.18892966 |
| 137 | Supraventricular tachycardia (HP:0004755) | 2.18392077 |
| 138 | Lipid accumulation in hepatocytes (HP:0006561) | 2.17963696 |
| 139 | Meningitis (HP:0001287) | 2.16021167 |
| 140 | Hyperlipoproteinemia (HP:0010980) | 2.15327038 |
| 141 | Obstructive lung disease (HP:0006536) | 2.14743307 |
| 142 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14743307 |
| 143 | Abnormality of purine metabolism (HP:0004352) | 2.14459501 |
| 144 | Keratitis (HP:0000491) | 2.14388109 |
| 145 | Acne (HP:0001061) | 2.13998042 |
| 146 | Abnormality of the calf musculature (HP:0001430) | 2.13212218 |
| 147 | Joint swelling (HP:0001386) | 2.13041643 |
| 148 | Increased IgM level (HP:0003496) | 2.11782846 |
| 149 | Dilated cardiomyopathy (HP:0001644) | 2.11153937 |
| 150 | Gingivitis (HP:0000230) | 2.11098530 |
| 151 | Glycosuria (HP:0003076) | 2.10387391 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 2.10387391 |
| 153 | Supraventricular arrhythmia (HP:0005115) | 2.09573213 |
| 154 | Bundle branch block (HP:0011710) | 2.08466900 |
| 155 | Ragged-red muscle fibers (HP:0003200) | 2.07738730 |
| 156 | Cerebral inclusion bodies (HP:0100314) | 2.04874772 |
| 157 | Apathy (HP:0000741) | 2.03626898 |
| 158 | Hypoalphalipoproteinemia (HP:0003233) | 2.03591677 |
| 159 | Increased IgE level (HP:0003212) | 2.02840325 |
| 160 | Conjunctival hamartoma (HP:0100780) | 2.02138411 |
| 161 | Urticaria (HP:0001025) | 2.01830052 |
| 162 | Epidermoid cyst (HP:0200040) | 2.00928983 |
| 163 | Basal ganglia calcification (HP:0002135) | 1.99829951 |
| 164 | Gout (HP:0001997) | 1.99321385 |
| 165 | Skin nodule (HP:0200036) | 1.99075567 |
| 166 | CNS demyelination (HP:0007305) | 1.98228261 |
| 167 | Methylmalonic aciduria (HP:0012120) | 1.97454795 |
| 168 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96941329 |
| 169 | Prolonged partial thromboplastin time (HP:0003645) | 1.95702022 |
| 170 | Diminished motivation (HP:0000745) | 1.93591015 |
| 171 | Hydroxyprolinuria (HP:0003080) | 1.92965744 |
| 172 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.92916337 |
| 173 | Abnormality of iron homeostasis (HP:0011031) | 1.92616633 |
| 174 | Malnutrition (HP:0004395) | 1.92398763 |
| 175 | Hypergammaglobulinemia (HP:0010702) | 1.91496460 |
| 176 | Complement deficiency (HP:0004431) | 1.86330874 |
| 177 | Glomerulopathy (HP:0100820) | 1.86050442 |
| 178 | Memory impairment (HP:0002354) | 1.85523635 |
| 179 | Abnormality of B cell number (HP:0010975) | 1.84738348 |
| 180 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83741454 |
| 181 | Alveolar cell carcinoma (HP:0006519) | 1.82002259 |
| 182 | Recurrent bronchitis (HP:0002837) | 1.80792577 |
| 183 | Gingival bleeding (HP:0000225) | 1.79830315 |
| 184 | Agnosia (HP:0010524) | 1.79795366 |
| 185 | Arthralgia (HP:0002829) | 1.77795314 |
| 186 | Eosinophilia (HP:0001880) | 1.76387007 |
| 187 | Chest pain (HP:0100749) | 1.76352173 |
| 188 | Stomach cancer (HP:0012126) | 1.75074830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.26076826 |
| 2 | PBK | 3.72533830 |
| 3 | IRAK3 | 3.51344717 |
| 4 | BCKDK | 3.33922238 |
| 5 | PDK4 | 3.27734813 |
| 6 | PDK3 | 3.27734813 |
| 7 | MAP3K14 | 3.21519650 |
| 8 | FRK | 2.66977078 |
| 9 | PDK2 | 2.63118468 |
| 10 | TBK1 | 2.62609743 |
| 11 | ACVR1B | 2.38842757 |
| 12 | DDR2 | 2.37224587 |
| 13 | NEK1 | 2.25585672 |
| 14 | RIPK1 | 2.17904821 |
| 15 | OBSCN | 2.07100479 |
| 16 | NME2 | 2.06639280 |
| 17 | TTN | 2.03228390 |
| 18 | MYLK | 2.01102604 |
| 19 | PINK1 | 1.98693033 |
| 20 | TAOK1 | 1.94071725 |
| 21 | IRAK4 | 1.78677322 |
| 22 | MAP4K1 | 1.76553451 |
| 23 | ABL2 | 1.67764627 |
| 24 | ARAF | 1.66434243 |
| 25 | IKBKE | 1.64079306 |
| 26 | TYK2 | 1.64044913 |
| 27 | ADRBK2 | 1.61455834 |
| 28 | GRK7 | 1.53323081 |
| 29 | MAP2K3 | 1.50677889 |
| 30 | PHKG1 | 1.49248620 |
| 31 | PHKG2 | 1.49248620 |
| 32 | CDC42BPA | 1.48118629 |
| 33 | MAP3K5 | 1.44600819 |
| 34 | TGFBR2 | 1.40343315 |
| 35 | BLK | 1.40311892 |
| 36 | STK24 | 1.37685656 |
| 37 | BMPR2 | 1.25161111 |
| 38 | MOS | 1.24417116 |
| 39 | ERBB4 | 1.23082169 |
| 40 | ZAP70 | 1.22165454 |
| 41 | MUSK | 1.21840497 |
| 42 | NEK9 | 1.21445703 |
| 43 | ERN1 | 1.21332328 |
| 44 | MAP3K12 | 1.20549498 |
| 45 | TAOK3 | 1.20008368 |
| 46 | IKBKB | 1.19648408 |
| 47 | EIF2AK1 | 1.16532116 |
| 48 | EPHA3 | 1.16319617 |
| 49 | CASK | 1.14897439 |
| 50 | LMTK2 | 1.14757521 |
| 51 | MAP3K11 | 1.11644417 |
| 52 | JAK1 | 1.10369034 |
| 53 | ZAK | 1.05158430 |
| 54 | DAPK2 | 1.04912022 |
| 55 | JAK3 | 1.03818185 |
| 56 | DAPK3 | 1.02469129 |
| 57 | MST1R | 0.98503719 |
| 58 | AKT3 | 0.95696274 |
| 59 | STK38L | 0.94849974 |
| 60 | PIM2 | 0.91493218 |
| 61 | PLK2 | 0.90955903 |
| 62 | TXK | 0.89273893 |
| 63 | MAP3K13 | 0.88281334 |
| 64 | PIK3CA | 0.84875161 |
| 65 | TYRO3 | 0.82680000 |
| 66 | PDPK1 | 0.77184156 |
| 67 | EPHB1 | 0.76951047 |
| 68 | HCK | 0.75754316 |
| 69 | PRKCD | 0.75495618 |
| 70 | JAK2 | 0.73418632 |
| 71 | STK4 | 0.71841309 |
| 72 | EIF2AK2 | 0.71412214 |
| 73 | CAMK2D | 0.71409522 |
| 74 | LATS2 | 0.70407297 |
| 75 | LCK | 0.69254736 |
| 76 | MAP2K4 | 0.68859215 |
| 77 | NLK | 0.65685814 |
| 78 | MARK3 | 0.65299010 |
| 79 | BTK | 0.64981739 |
| 80 | YES1 | 0.63401868 |
| 81 | SIK3 | 0.62718049 |
| 82 | PRKCE | 0.62044543 |
| 83 | DAPK1 | 0.61815244 |
| 84 | PIM1 | 0.61209389 |
| 85 | FGFR3 | 0.58522698 |
| 86 | PDGFRB | 0.57852235 |
| 87 | CAMK2G | 0.57318782 |
| 88 | MAP2K6 | 0.56265824 |
| 89 | CSK | 0.56106881 |
| 90 | DYRK3 | 0.55651011 |
| 91 | BRAF | 0.55289479 |
| 92 | INSRR | 0.55272565 |
| 93 | FGR | 0.54844385 |
| 94 | IRAK2 | 0.54840124 |
| 95 | PDK1 | 0.53955631 |
| 96 | PRKAA2 | 0.53609034 |
| 97 | KSR2 | 0.53160811 |
| 98 | IRAK1 | 0.52420698 |
| 99 | PRKACG | 0.51478323 |
| 100 | MAP3K3 | 0.50490104 |
| 101 | MARK2 | 0.50239446 |
| 102 | FGFR4 | 0.49843362 |
| 103 | MAP3K1 | 0.49481791 |
| 104 | HIPK2 | 0.49052159 |
| 105 | NME1 | 0.48853461 |
| 106 | PKN1 | 0.48518368 |
| 107 | KIT | 0.48508257 |
| 108 | CHUK | 0.48242380 |
| 109 | STK10 | 0.47131183 |
| 110 | CAMK2A | 0.46644090 |
| 111 | FES | 0.46349821 |
| 112 | PRPF4B | 0.45636498 |
| 113 | SIK2 | 0.45466106 |
| 114 | MELK | 0.45306120 |
| 115 | TRPM7 | 0.45257871 |
| 116 | TAOK2 | 0.45064542 |
| 117 | CSF1R | 0.44631554 |
| 118 | CLK1 | 0.44519495 |
| 119 | CAMKK2 | 0.44288400 |
| 120 | CAMK1D | 0.43588633 |
| 121 | KDR | 0.42700864 |
| 122 | PDGFRA | 0.42665112 |
| 123 | SGK2 | 0.41447913 |
| 124 | MAP2K7 | 0.41294409 |
| 125 | SGK3 | 0.40983875 |
| 126 | FLT3 | 0.40134336 |
| 127 | MST4 | 0.38924375 |
| 128 | MAPK7 | 0.38871485 |
| 129 | TNK2 | 0.38846673 |
| 130 | MAPK12 | 0.38469126 |
| 131 | SYK | 0.38333494 |
| 132 | GRK5 | 0.37551383 |
| 133 | CAMK4 | 0.36868102 |
| 134 | TIE1 | 0.35197284 |
| 135 | MAPK4 | 0.35054691 |
| 136 | MATK | 0.34662406 |
| 137 | PRKAA1 | 0.34534478 |
| 138 | WNK3 | 0.33398577 |
| 139 | MAP2K1 | 0.33390131 |
| 140 | LYN | 0.33229958 |
| 141 | PRKG2 | 0.33143797 |
| 142 | EGFR | 0.32627153 |
| 143 | TRIB3 | 0.32468272 |
| 144 | PRKCZ | 0.32249403 |
| 145 | PRKCG | 0.32132186 |
| 146 | TEC | 0.31025606 |
| 147 | ABL1 | 0.30287424 |
| 148 | RPS6KA6 | 0.29048738 |
| 149 | PIK3CG | 0.26911317 |
| 150 | CDK6 | 0.24987527 |
| 151 | MAP3K6 | 0.22368669 |
| 152 | BMX | 0.22078471 |
| 153 | ITK | 0.21919960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.32921173 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27464730 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.20501637 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.94595059 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.75237018 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47134661 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.39384877 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.33520579 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33209490 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.18993327 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.14491603 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.10472233 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03568725 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 2.01645388 |
| 15 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.87922673 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83140460 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80917676 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.80251871 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.79682464 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.71333816 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.67526241 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.65007758 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.63758891 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.62420541 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.60644437 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59069689 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58845993 |
| 28 | * Peroxisome_Homo sapiens_hsa04146 | 1.55632827 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51924299 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49116590 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.48653537 |
| 32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.47948267 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47803069 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45992808 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43219290 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.39354123 |
| 37 | Proteasome_Homo sapiens_hsa03050 | 1.38439235 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37302530 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.36157394 |
| 40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.34375975 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31260692 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30796078 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27206726 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26029960 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25481363 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21889136 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21887570 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.20056054 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13962223 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.13427673 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13299187 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.11888840 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11618266 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09550694 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06637542 |
| 56 | Pertussis_Homo sapiens_hsa05133 | 1.05907059 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03931609 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03485571 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.02340462 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01492308 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01244092 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01126766 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.99950655 |
| 64 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.99265463 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.98923294 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.98882001 |
| 67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98459707 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98210068 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.97275177 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97254001 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.96886162 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96821984 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96676155 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96204917 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95738939 |
| 76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93670752 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93453684 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.92652089 |
| 79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91966211 |
| 80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91647198 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91638897 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.90668195 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89236005 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85697020 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85195549 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.81194850 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.79838236 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79042210 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.75732021 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74243956 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73956389 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73546179 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72406134 |
| 94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72227289 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72028575 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.71994620 |
| 97 | Shigellosis_Homo sapiens_hsa05131 | 0.70510059 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69372780 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.69136086 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68623786 |
| 101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66763924 |
| 102 | Influenza A_Homo sapiens_hsa05164 | 0.63309522 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60312703 |
| 104 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59647197 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59457504 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58619471 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.58274629 |
| 108 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57091205 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56027335 |
| 110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55095506 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54289950 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54079322 |
| 113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53092858 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52440522 |
| 115 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.52034112 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51760342 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51742363 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50362563 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49307894 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48491448 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47651157 |
| 122 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46774518 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46558350 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.46185686 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45972665 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45489290 |
| 127 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45312259 |
| 128 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45220932 |
| 129 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43931998 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43367202 |
| 131 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42808535 |
| 132 | Measles_Homo sapiens_hsa05162 | 0.42555633 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41971151 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.41850524 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41406833 |
| 136 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41371257 |
| 137 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40891484 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.40150040 |
| 139 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39678291 |
| 140 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39669188 |
| 141 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39398403 |
| 142 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39089567 |
| 143 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39051720 |
| 144 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36905469 |
| 145 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36363879 |
| 146 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35977538 |
| 147 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35850607 |
| 148 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35827575 |
| 149 | ABC transporters_Homo sapiens_hsa02010 | 0.34904027 |
| 150 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34850810 |
| 151 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34558455 |
| 152 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30438712 |
| 153 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28883681 |
| 154 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28422765 |
| 155 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28377637 |
| 156 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27445350 |
| 157 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27219429 |
| 158 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.21585587 |
| 159 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21337199 |
| 160 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18934133 |
| 161 | Prostate cancer_Homo sapiens_hsa05215 | 0.17785891 |

